Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Ciruelos, E; Jerusalem, G; Martin, M; Tjan-Heijnen, VCG; Neven, P; Gavila, J; Montemurro, F; Generali, D; Lang, I; Mart?nez-Serrano, MJ; Perello, MF; Conte, P.

Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population

CLINICAL & TRANSLATIONAL ONCOLOGY. 2020; 22(10): 1857-1866 Nº de citas: 3 [doi:10.1007/s12094-020-02327-5]

Calles, A; Aparicio, MI; Alva, M; Bringas, M; Gutierrez, N; Soto, J; Arregui, M; Tirado, VC; Alvarez, EL; del Monte-Millan, M; Massarrah, T; Galera, M; Alvarez, R; Martin, M.

Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid

Frontiers in Oncology. 2020; 10: Nº de citas: 31 [doi:10.3389/fonc.2020.01777]

Escudero-Vilaplana, V; Calles, A; Collado-Borrell, R; Marzal-Alfaro, MB; Polanco, C; Garrido, C; Suarez, J; Ortiz, A; Appierto, M; Comellas, M; Lizan, L.

Standardizing Health Outcomes for Lung Cancer. Adaptation of the International Consortium for Health Outcomes Measurement Set to the Spanish Setting

Frontiers in Oncology. 2020; 10: Nº de citas: 8 [doi:10.3389/fonc.2020.01645]

Fernandez-Montes, A; Gravalos, C; Pericay, C; Safont, MJ; Benavides, M; EElez, E; Garcia-Alfonso, P; Garcia-Paredes, B; Carrato, A; Aranda, E.

Current Options for Third-line and Beyond Treatment of Metastatic Colorectal Cancer. Spanish TTD Group Expert Opinion

CLINICAL COLORECTAL CANCER. 2020; 19(3): 165-177 Nº de citas: 14 [doi:10.1016/j.clcc.2020.04.003]

Nunez-Torres, R; Martin, M; Garcia-Saenz, JA; Rodrigo-Faus, M; del Monte-Millan, M; Tejera-Perez, H; Pita, G; de la Torre-Montero, JC; Pinilla, K; Herraez, B; Peiro-Chova, L; Bermejo, B; Lluch, A; Gonzalez-Neira, A.

Association Between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women With Breast Cancer

JAMA Dermatology. 2020; 156(9): 987-991 Nº de citas: 10 [doi:10.1001/jamadermatol.2020.1867]

Sastre, J; de la Orden, V; Martinez, A; Bando, I; Balbin, M; Bellosillo, B; Palanca, S; Gomez, MIP; Mediero, B; Llovet, P; Moral, VM; Vieitez, JM; Garcia-Alfonso, P; Calle, SG; Ortiz-Morales, MJ; Salud, A; Quintero, G; Lopez, C; Diaz-Rubio, E; Aranda, E.

Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naive Metastatic Colorectal Cancer Patients Prospectively Collected

CLINICAL COLORECTAL CANCER. 2020; 19(3): 110-116 Nº de citas: 26 [doi:10.1016/j.clcc.2020.02.014]

Martin, M; Guerrero-Zotano, A; Montero, A; Jara, C; Filipovich, E; Rojo, F; Moreno, F; Garcia-Saenz, JA; Ales, JE; Chacon, JI; Cruz, J; Gimenez, J; Cruz-Merino, L; Algara, M; Santisteban, M; Tarruella, SL.

GEICAMGuidelines for the Management of Patients with Breast Cancer During theCOVID-19 Pandemic in Spain

ONCOLOGIST. 2020; 25(9): 1339-1345 Nº de citas: 11 [doi:10.1634/theoncologist.2020-0363]

Moran, T; Taus, A; Arriola, E; Aguado, C; Domine, M; Rueda, AG; Calles, A; Cedres, S; Vinolas, N; Isla, D; Palmero, R; Sereno, M; Diaz, V; Juan, O; Marse, R; Martorell, PM; Torres, JMS; Uncommon EGFR Mutations Spain.

Clinical Activity of Afatinib in Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Spanish Retrospective Multicenter Study

CLINICAL LUNG CANCER. 2020; 21(5): 428 Nº de citas: 15 [doi:10.1016/j.cllc.2020.04.011]

Aviles-Izquierdo, JA; Nieto-Benito, LM; Lazaro-Ochaita, P; Escat-Cortes, JL; Marquez-Rodas, I; Mercader-Cidoncha, E.

Prognostic significance of sentinel node biopsy status in cutaneous melanoma: a 21-years prospective study from a single institution

CLINICAL & TRANSLATIONAL ONCOLOGY. 2020; 22(9): 1611-1618 [doi:10.1007/s12094-020-02306-w]

Friedlaender, A; Metro, G; Signorelli, D; Gili, A; Economopoulou, P; Roila, F; Banna, G; De Toma, A; Camerini, A; Christopoulou, A; Lo Russo, G; Banini, M; Galetta, D; Jimenez, B; Collazo-Lorduy, A; Calles, A; Baxevanos, P; Linardou, H; Kosmidis, P; Mountzios, G; Garassino, MC; Addeo, A.

Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score >= 50% treated with front-line pembrolizumab

Acta Oncologica. 2020; 59(9): 1058-1063 Nº de citas: 34 [doi:10.1080/0284186X.2020.1781249]

Van Cutsem, E; Danielewicz, I; Saunders, MP; Pfeiffer, P; Argiles, G; Borg, C; Glynne-Jones, R; Punt, CJA; Van de Wouw, AJ; Fedyanin, M; Stroyakovskiy, D; Kroening, H; Garcia-Alfonso, P; Wasan, H; Falcone, A; Kanehisa, A; Egorov, A; Aubel, P; Amellal, N; Moiseenko, V.

Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study

ANNALS OF ONCOLOGY. 2020; 31(9): 1160-1168 Nº de citas: 47 [doi:10.1016/j.annonc.2020.05.024]

Goetz, MP; Martin, M; Tokunaga, E; Park, IH; Huober, J; Toi, M; Stoffregen, C; Shekarriz, S; Andre, V; Gainford, MC; Price, GL; Johnston, S.

Health-RelatedQuality of Life inMONARCH3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy inHR+,HER2-Advanced Breast Cancer

ONCOLOGIST. 2020; 25(9): 1346-1354 Nº de citas: 43 [doi:10.1634/theoncologist.2020-0084]

Escudero-Vilaplana, V; Collado-Borrell, R; Hoyo-Munoz, A; Gimenez-Manzorro, A; Calles, A; Osorio, S; Herranz-Alonso, A; Sanjurjo-Saez, M.

Potential drug interactions between targeted oral antineoplastic agents and concomitant medication in clinical practice

EXPERT OPINION ON DRUG SAFETY. 2020; 19(8): 1041-1048 Nº de citas: 9 [doi:10.1080/14740338.2020.1781089]

Vera, R; Gomez, ML; Ayuso, JR; Figueras, J; Garcia-Alfonso, P; Martinez, V; Lacasta, A; Ruiz-Casado, A; Safont, MJ; Aparicio, J; Campos, JM; Camara, JC; Martin-Richard, M; Montagut, C; Pericay, C; Vieitez, JM; Falco, E; Jorge, M; Marin, M; Salgado, M; Viudez, A.

Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study

Cancers. 2020; 12(8): Nº de citas: 9 [doi:10.3390/cancers12082259]

Izquierdo, JAA; Lopez, IM; Morillo, PS; Rodas, IM; Cidoncha, EM.

Utility of PET/CT in patients with stage I-III melanoma

CLINICAL & TRANSLATIONAL ONCOLOGY. 2020; 22(8): 1414-1417 Nº de citas: 8 [doi:10.1007/s12094-019-02252-2]

Camps Herrero, C; Batista, N; Diaz Fernandez, N; Escobar Alvarez, Y; Gonzalo Gomez, A; Isla Casado, D; Salud, A; Terrasa Pons, J; Guillem Porta, V.

Breakthrough cancer pain: review and calls to action to improve its management

CLINICAL & TRANSLATIONAL ONCOLOGY. 2020; 22(8): 1216-1226 Nº de citas: 26 [doi:10.1007/s12094-019-02268-8]

Carmona-Bayonas, A; Gomez, D; de Castro, EM; Segura, PP; Langa, JM; Jimenez-Fonseca, P; Canovas, MS; Moran, LO; Escobar, IG; Blanco, ABR; Perez, IF; de Prado, PM; Balanya, RPI; Verduguez, TQ; Rodriguez-Lescure, A; Munoz, A.

A snapshot of cancer-associated thromboembolic disease in 2018-2019: First data from the TESEO prospective registry

EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2020; 78: 41-49 Nº de citas: 29 [doi:10.1016/j.ejim.2020.05.031]

Galeano-Valle, F; Perez-Rus, G; Demelo-Rodriguez, P; Ordieres-Ortega, L; Ortega-Moran, L; Munoz-Martin, AJ; Medina-Molina, S; Alvarez-Sala-Walther, LA; del-Toro-Cervera, J.

Monitoring anti-Xa levels in patients with cancer-associated venous thromboembolism treated with bemiparin

CLINICAL & TRANSLATIONAL ONCOLOGY. 2020; 22(8): 1312-1320 Nº de citas: 2 [doi:10.1007/s12094-019-02258-w]